United States · FDA National Drug Code directory
Cobenfy
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0003-0125_88ec22d3-785d-45e6-bda1-be532e75bcbc
- Product NDC
- 0003-0125
- Form
- CAPSULE, COATED PELLETS
- Composition / generic term
- xanomeline and trospium chloride
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240927
- Source listing expiry
- 20271231
Source-listed ingredients
- XANOMELINE — 125 mg/1
- TROSPIUM CHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0003-0125-14) · 0003-0125-14
- 60 CAPSULE, COATED PELLETS in 1 BOTTLE (0003-0125-60) · 0003-0125-60
- 10 BLISTER PACK in 1 CARTON (0003-0125-98) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK · 0003-0125-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →